The older patients Randomised Interventional Trial in Acute non-st elevation myocardial infarction:the SENIOR-RITA trial

Every year, thousands of older patients with a serious type of heart attack are sent home without a procedure to reopen their blocked arteries, because doctors worry the treatment might kill them. This matters because the evidence behind that caution is weak. The population is ageing, and age is a powerful predictor of death after a heart attack—the odds of dying in hospital rise by 70% for every decade of life. Among patients aged 75 and over with a non-ST elevation myocardial infarction (NSTEMI), up to half are severely frail, and those frail patients have a four-fold higher risk of death within a year. Yet many are denied coronary revascularisation (stenting or bypass surgery) simply from fear of complications. The SENIOR-RITA trial directly tests whether that fear is justified, by randomly assigning high-risk older NSTEMI patients to either revascularisation or conservative medical management, and tracking survival, quality of life, and frailty scores. If the trial shows revascularisation is safe and beneficial in this group, it could immediately change clinical guidelines and hospital protocols. Thousands of older patients each year would gain access to a treatment that currently is withheld, potentially reducing deaths and improving quality of life in a rapidly growing segment of the population.